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A knockdown study suggested that transcription factor AP-2 alpha (Tfap2a) is required for neural crest induction in frog embryos. However,
because Tfap2a is expressed in neural crest and in presumptive epidermis, a source of signals that induce neural crest, it was unclear whether this
requirement is cell autonomous. Moreover, neural crest induction occurs normally in zebrafish tfap2a and mouse Tcfap2a mutant embryos, so it
was unclear if a requirement for Tfap2a in this process has been evolutionarily conserved. Here we show that zebrafish tfap2c, encoding AP-2
gamma (Tfap2c), is expressed in non-neural ectoderm including transiently in neural crest. Inhibition of tfap2c with antisense oligonucleotides
does not visibly perturb development. However, simultaneous inhibition of tfap2a and tfap2c utterly prevents neural crest induction, supporting a
conserved role for Tfap2-type activity in neural crest induction. Transplant studies suggest that this role is cell-autonomous. In addition, in tfap2a/
tfap2c doubly deficient embryos cranial placode derivatives are reduced, although gene expression characteristic of pre-placodal domain is
normal. Unexpectedly, Rohon-Beard sensory neurons, which previous studies indicated are derived from the same precursor population as neural
crest, are reduced by less than half in such embryos, implying a non-neural crest origin for a subset of them.
© 2007 Elsevier Inc. All rights reserved.Keywords: Activator protein 2 alpha; Activator protein 2 gamma; Neural crest; Placode; Rohon–Beard; Transcription factor; Epidermis; Pectoral fin; tfap2a; tfap2cIntroduction
The neural crest is a population of precursor cells that
migrate from the dorsal neural tube and give rise to diverse
derivatives. Neural crest induction refers to the specification of
ectoderm cells to the neural crest lineage. This process is of
particular interest because it reflects events in the emergence of
neural crest during vertebrate evolution. It is believed that
combinatorial activity of transcription factors expressed at the
neural plate border governs neural crest induction, but the
functions of specific transcription factors in this process are not
yet clear (Hong and Saint-Jeannet, 2005; Sauka-Spengler and
Bronner-Fraser, 2006; Steventon et al., 2005).⁎ Corresponding author. Department of Anatomy and Cell Biology, Carver
College of Medicine, University of Iowa, Iowa City, IA 52242, USA.
E-mail address: robert-cornell@uiowa.edu (R.A. Cornell).
0012-1606/$ - see front matter © 2007 Elsevier Inc. All rights reserved.
doi:10.1016/j.ydbio.2006.12.042The Tfap2 (AP-2 or Activator Protein 2) family of
transcription factors is implicated in control of cell induction,
differentiation, survival, and proliferation in various develop-
mental contexts, including the neural crest (reviewed in Eckert
et al., 2005; Hilger-Eversheim et al., 2000). In mouse, the five
Tfap2 proteins, a–e, are encoded by the genes Tcfap2a,
Tcfap2b, etc., respectively; in humans and frogs the orthologues
of these genes are TFAP2A, etc., and in zebrafish, they are
known as tfap2a, etc. The five proteins share a conserved
structure, and with the exception of Tfap2d, they share very
similar DNA binding specificity (Eckert et al., 2005). Mutant
analysis has shown that Tfap2a is essential for normal
development of neural crest derivatives (Holzschuh et al.,
2003; Knight et al., 2004; Schorle et al., 1996; Zhang et al.,
1996). However the role of Tfap2a specifically in neural crest
induction has remained uncertain, because disruption of Tfap2a
expression has different effects in different species. Oligonu-
cleotide-mediated knock down of TFAP2A in frog embryos
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Sox9, two markers of pre-migratory neural crest, and forced
expression of TFAP2A in neural plate or in explanted,
neuralized ectoderm induced ectopic expression of these
genes (Luo et al., 2003, 2005). These experiments suggested
that Tfap2a is required for specification of neural crest in frogs,
in a cell autonomous or non-autonomous mode. By contrast, in
mouse and zebrafish Tcfap2a (tfap2a) strong hypomorphic or
null mutants induction and migration of neural crest appear to
occur essentially normally (Barrallo-Gimeno et al., 2004;
Knight et al., 2003; Schorle et al., 1996; Zhang et al., 1996).
These disparities suggested the possibility that a role for Tfap2-
type activity in neural crest induction might not be a conserved
feature among vertebrates.
Alternatively, there may be variation among species in the
degree to which neural crest induction is shared among Tfap2
family members. Tcfap2a, Tcfap2b, and Tcfap2c are all
expressed in neural crest in mouse (Chazaud et al., 1996;
Mitchell et al., 1991; Moser et al., 1997), and there is evidence
that Tfap2 family members act redundantly in development. For
instance, Tcfap2a and Tcfap2c are co-expressed in extra-
embryonic tissue (Auman et al., 2002; Werling and Schorle,
2002; Winger et al., 2006). Mouse Tcfap2c mutants die at
8.5 days post coitum (dpc) because of abnormal placental
function (Auman et al., 2002; Werling and Schorle, 2002). By
contrast, mouse Tcfap2a mutant embryos live considerably
longer, until shortly after birth (Schorle et al., 1996; Zhang et
al., 1996). Embryos doubly mutant for Tcfap2a and Tcfap2c die
at 3.5 dpc, i.e., even earlier than Tcfap2c mutants, consistent
with redundant activity of these proteins within extra embryonic
tissue during mouse peri-implantation development (Winger et
al., 2006). In another example, zebrafish tfap2b is expressed in
the hindbrain and, like tfap2a, in non-neural ectoderm flanking
the hindbrain (Knight et al., 2005). Oligonucleotide-mediated
knockdown of tfap2b did not visibly perturb development, but
simultaneous inhibition of tfap2a and tfap2b resulted in far
more severe defects in craniofacial cartilage than in tfap2a
mutants, apparently because of redundant activity of Tfap2a and
Tfap2b in cranial epidermis (Knight et al., 2005). Because
Tfap2 family members appear to act redundantly in other
developmental contexts they may do so during neural crest
induction.
A second open question regarding the role of Tfap2-type
activity in neural crest induction is whether this role is direct or
indirect. In mice and zebrafish, Tcfap2a/tfap2a is expressed
from gastrula stages in premigratory neural crest, but also in
non-neural ectoderm flanking the neural crest. Explant studies
have shown that non-neural ectoderm is the source of signals
that induce neural crest (Dickinson et al., 1995; Liem et al.,
1995; Moury and Jacobson, 1990; Selleck and Bronner-Fraser,
1995), so it is possible the production of these signals depends
on Tfap2-type activity. Consistent with this possibility, there is
evidence that signals from adjacent tissues that instill pattern on
neural crest cells depend on Tfap2-type activity. Thus, in mouse
Tcfap2a mutant embryos and zebrafish tfap2a mutant embryos,
there is a profound reduction in a subset of neural crest
derivatives including the jaw (Barrallo-Gimeno et al., 2004;Holzschuh et al., 2003; Knight et al., 2003; Schorle et al., 1996;
Zhang et al., 1996). However, this dependence of jaw
development on Tfap2a is at least partially cell non-autono-
mous, because mouse embryos with Wnt1-Cre mediated neural
crest-specific elimination of Tcfap2a have normal jaws (Brewer
et al., 2004), and the presence of wild-type pharyngeal ectoderm
can partially rescue the development of the jaw in zebrafish
tfap2a mutants (Knight et al., 2005). These examples illustrate
that non-autonomous effects of Tfap2-type activity on neural
crest development are possible.
Here we address both of these issues in zebrafish embryos.
We present evidence that redundant activity of Tfap2a and
Tfap2c is required for neural crest induction, and that this
requirement is cell autonomous. Unexpectedly, Rohon–Beard
spinal sensory neurons, which share properties with neural crest
(Cornell and Eisen, 2000, 2002; Artinger et al., 1999), are
merely reduced in embryos deficient in Tfap2a and Tfap2c.
These findings suggest that Tfap2-type activity, mediated by
Tfap2a and Tfap2c, is a conserved, and cell-autonomous
requirement of neural crest induction. We also describe severe
reduction of cranial placode derivatives, but no evidence of a
failure of induction of the pre-placodal domain, in embryos
deficient in both genes.Materials and methods
Fish maintenance
Zebrafish embryos and adults were reared as described (Westerfield, 1993)
in the University of Iowa Zebrafish Facility. Embryos were staged by hours or
days post fertilization at 28.5 °C (hpf or dpf) (Kimmel et al., 1995). To generate
tfap2a homozygous mutant embryos, heterozygous adults harboring a presumed
null allele of tfap2a (lockjaw Knight et al., 2003) were used.
Zebrafish Tfap2 orthologues
Three putative genes encoding zebrafish Tfap2 orthologues were found in
the database of the Zebrafish Information Network (ZFIN, http://zfin.org).
Genbank accession numbers for these genes are listed: tfap2c, NM_001008576;
tfap2d, NM_00102554; tfap2e, NM_200821.
RT-PCR and morpholinos
First-strand cDNAwas synthesized from total RNA harvested from embryos
at 24 hpf as described (O'Brien et al., 2004). A 1.3 kb fragment of zebrafish
tfap2c was amplified from the wild-type cDNA by using the following primers:
forward, 5′-GTTAGC AGC AAT GGG AAC CCT C-3′, reverse, 5′-GGTACC
ATC GGA AGA GGC TTG T-3′, and inserted into pCR4-TOPO vector
(Invitrogen, Carlsbad, CA). This fragment includes most of the open reading
frame (i.e., encoding amino acids 22 to 434 of 445).
To disrupt tfap2c expression, the exon 3 splice donor site and the exon 4
splice acceptor site were inferred in zebrafish tfap2c gene by comparison of
cDNA sequence to tfap2c genomic sequence (www.ensembl.org/Danio_rerio/
index.html, zgc92088). Morpholinos complementary to these sites were
ordered: tfap2c e3i3 MO, 5′-TCT GAC ATC AAC TCA CCT GAA CATC-
3′; tfap2c i3e4MO, 5′-CAT CGT GCT GCA ATA AAA CAA AAT G-3′ (Gene
Tools, Philomath, OR). For a negative control, the vendor's standard control
morpholino (5′-CCT CTT ACC TCA GTT ACA ATT TAT A-3′), which is
thought to have no specific target in animal cells, was used. Morpholinos were
reconstituted to 5 mg/ml in Danieau solution (Nasevicius and Ekker, 2000) and
stored at − 20 °C, then diluted immediately before use to 1 mg/ml in 0.2 M KCl.
Embryos were injected with 4–8 nl of diluted morpholinos at the 1–4 cell stage
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specific toxicity, i.e., patches of opacity in the brain and spinal cord, upon
injection of 10 ng or more of either MO. However, injection of 5 ng of either
tfap2c MO did not cause this phenotype. We compared efficiency of the MO,
and found that 2.5 ng/embryo of tfap2c e3i3MO was virtually always sufficient
to eliminate melanophores in tfap2a homozygous mutants, while 5.0 ng/embryo
of tfap2c i3e4 MO was necessary for this effect. To assure strong penetrance,
5 ng/embryo of tfap2c e3i3MO was used to generate tfap2a−/cMO embryos. For
double MO experiments, 5 ng of tfap2c e3i3 MO and 2.5 ng tfap2a e2i2 MO
were injected. ngn1 (neurog-1) MO (Cornell and Eisen, 2002) was used at
1.5 ng/embryo. To test the efficacy of tfap2c MOs, a pair of primers flanking a
557 bp fragment between the exon 3 and exon 5 of tfap2c was used for RT-PCR
(forward, 5′-AAC CCAGCGACC CATACT CTC A-3′; reverse, 5′-TCC AAG
CAG GGATGC GTT CA-3′).
Chimeric embryo procedure
To create genetic chimeras, donor embryos were injected with 5 nl of 1%
lysine-fixable biotinylated-dextran, 10,000 MW (Sigma, St. Louis, MO). At
sphere stage (4 hpf), about 100 cells were withdrawn from each donor embryo
with a manual-drive syringe fitted with an oil-filled needle (Fine Science Tools,
Vancouver, BC), and about 20 cells were inserted into each of several host
embryos at the same stage, aiming for a position close to the animal pole, to
target clones to ectoderm (Kimmel et al., 1990). Host embryos were allowed to
develop to 12 hpf, fixed and processed to reveal foxd3 gene expression by whole
mount in situ hybridization and to reveal biotin with an ABC kit (Vector Labs,
Burlingame, CA) and DAB as previously described (Moens and Fritz, 1999).
Some host embryos were allowed to develop to 48 hpf, fixed and processed to
reveal biotin.
Misexpression and rescue experiments
For rescue experiments, the open reading frame of zebrafish tfap2a,
isoform AF457191, was amplified from cDNA prepared from 24 hpf embryos
using the following primers: forward, 5′-GCA GGATCC ATG AAA ATG CTT
TGG A-3′, with BamHI restriction site added to the 5′ end; reverse, 5′-TAG
TTC TAG ATT GGATAT CAC TTT CTG-3′, with XbaI restriction site added
to the 5′ end. The PCR product was ligated into pCS2+ vector, creating pCS2-
tfap2a-ORF. This construct was linearized with NotI and capped tfap2a mRNA
was generated in vitro with the mMessage mMachine kit (Ambion, Austin,
TX). For rescue experiments, tfap2a mRNA was injected at a final dose of
0.25–0.5 ng, mixed with tfap2a MO and tfap2c MO prior to injection. For
ectopic expression experiments, capped mRNA was synthesized in vitro from
the GRXAP2 plasmid (Luo et al., 2002) and injected at 0.6–0.8 ng in 0.2 M
KCl. lacz RNA was synthesized as described (Cornell and Eisen, 2000) and
used as a lineage tracer.
Gene expression analysis
DIG-labeled antisense RNA probes (Roche Diagnostics, Mannheim,
Germany) used for whole mount in situ hybridization were generated as
described previously: tfap2a, foxd3, sox10, dlx2 (O'Brien et al., 2004), isl1,
msxb (Cornell and Eisen, 2002), pax3 (Lewis et al., 2004), zic2b (Kudoh
et al., 2004), sox2 (Thisse et al., 2001), prdm1 (Hernandez-Lagunas et al.,
2005); or as follows: tfap2c, NotI/T3; sox9b (Yan et al., 2005), StuI/T7;
snai1b (Thisse et al., 1995), XbaI/T7; dlx3b (Akimenko et al., 1994), SalI/
T7; eya1 (Sahly et al., 1999), NotI/T7; and tlxA (Andermann and Weinberg,
2001), BamHI/T7. Two-color in situ hybridization analysis, using DIG-
labeled tfap2c probe and FITC-labeled foxd3 probe, was carried out as
described (O'Brien et al., 2004).
Markers of cranial ganglia, enteric neurons, sympathetic neurons, and dorsal
root ganglia, including anti-HNK1 (Zn12) (Trevarrow et al., 1990) and anti-Hu
(Marusich et al., 1994), were used in whole mount immunohistochemistry as
described (O'Brien et al., 2004). Double labeling with monoclonal antibody
mAb 39.4D5 (anti-Islet proteins) and DIG-labeled foxd3 or tfap2a probes were
performed as described (Cornell and Eisen, 2000). Alcian green was used to
label pharyngeal cartilage as described (Kimmel et al., 1998).Apoptosis, cell proliferation, and DASPEI assays
Apoptotic cell death was monitored in whole embryos by terminal
transferase dUTP nick-end labeling essentially as described (Reyes et al.,
2004), except dUTP-DIG was used. The terminal transferase reaction was
stopped by incubation at 70 °C for 30 min, and embryos were processed with
anti-DIG-alkaline phosphatase antibody and developed with NBT/BCIP, as for
an RNA in situ hybridization. zVAD-fmk (MP Biomedicals, Irvine, CA) was
diluted in fish water to 300 μM and added to the embryos at 6 hpf. To measure
proliferation, live embryos at 10 hpf were incubated for 20 min in 10 mM
bromodeoxyuridine (BrdU) (Roche Diagnostics Mannheim, Germany) in fish
water with 15% DMSO at 4 °C. Embryos were then rinsed in fish water and
allowed to develop till 11 hpf. Anti-bromodeoxyuridine mouse monoclonal
antibody (BMC 9318) (Roche Diagnostics, Indianapolis, IN) was used at 1:100
dilution, and developed with the PAP system (Abcam, Cambridge, MA) and
DAB. To label hair cells, live embryos were incubated in 1 mM DASPEI (2-(4-
dimethylaminostyryl)-N-ethylpyridinium iodide) (Biotium, Hayward, CA) for
60 min, rinsed for 30 min in embryo medium (Westerfield, 1993), and viewed
with epifluorescence optics.
Results
A zebrafish tfap2c orthologue is expressed in non-neural
ectoderm starting during gastrula stages
We looked for Tfap2 family members that are expressed at
the appropriate place and time to participate in neural crest
induction, i.e., in lateral ectoderm during gastrula stage.
Orthologues of Tcfap2c, Tcfap2d, and Tcfap2e in zebrafish
genomic DNA have been identified by sequence comparison
algorithms (www.ensembl.org/Danio_rerio). With RT-PCR we
amplified partial clones of at least 1 kb from each orthologue,
and examined expression of each in situ in embryos ranging
from 6 hpf (gastrula) to 48 hpf. Expression of neither tfap2d nor
tfap2e was detected in non-neural ectoderm during gastrula
stages, so these orthologues were not pursued in the context of
neural crest induction (WL and RAC, unpublished data). At 4-
cell stage, maternal tfap2c transcripts were detected by RT-PCR
(not shown). At 6 hpf, tfap2c expression was detected in non-
neural ectoderm (Fig. 1A), in a pattern similar or identical to
that of tfap2a (Fig. 1B). At 8.5 hpf, tfap2c expression was
found to at least partially overlap that of pax3, a marker of
prospective neural crest (Lewis et al., 2004) (Figs. 1C, D). By
11 hpf, tfap2c expression is high in prospective epidermis and
in the pre-placodal region (Fig. 1E). To learn whether tfap2c is
expressed in pre-migratory neural crest at this stage, we
processed embryos to reveal foxd3 in red and tfap2c in blue.
At 11 hpf, the most caudal foxd3 expressing cells in the neural
crest domain were found to also express tfap2c, while most of
the rostral foxd3 expressing cells do not express high-level
tfap2c (Figs. 1F, F′, F′′, H). Because foxd3 expression appears
in a rostral to caudal wave, these results suggest that neural crest
cells down-regulate tfap2c expression shortly after they begin
to express foxd3. To assess whether there is low level tfap2c
expression in the more rostral neural crest cells, i.e., which may
have been obscured by foxd3 expression in double-labeled
embryos, we processed embryos at the same stage for tfap2c
and sox2, a marker of the neural plate (Okuda et al., 2006). In
tfap2c/sox2 double-labeled embryos, cells immediately flank-
ing the cranial neural plate, which are neural crest cells, are
Fig. 1. Comparison of tfap2a and tfap2c expression at embryonic stages. (A, B) Lateral views, animal pole oriented up and dorsal side to the right, of panel A, tfap2c
and panel B, tfap2a expression in ventral and lateral ectoderm at 6 hpf. Arrowheads point to the limit of expression, which is similar or identical for the genes. (C, D)
Animal pole views of panel C, tfap2c and panel D, pax3 expression at 8.5 hpf. Expression of pax3 marks prospective neural crest (Lewis et al., 2004); tfap2c
expression partially or entirely overlaps it. (E–G) Dorsal views of flat-mounted embryos at 11 hpf, anterior to the left. (E) tfap2c expression is detected in non-neural
ectoderm (nne, asterisk), with increased levels immediately adjacent to the rostral neural plate, in the pre-placodal region (ppr, arrowheads). (F) Double RNA in situ
hybridization with foxd3 (red) and tfap2c (blue) probes. More caudal cells expressing foxd3, which are recently specified pre-migratory neural crest cells (pnc), also
express tfap2c (shown at higher magnification in panel F′, arrowhead indicates double-labeled cell). By contrast, at more rostral levels, tfap2c is expressed in ppr but is
excluded from the majority of foxd3 expressing cells (shown at higher magnification in panel F′′). (G) An embryo labeled with tfap2c and sox2, a pan-neural plate
marker (Okuda et al., 2006). tfap2c expression is absent from cells immediately lateral to the neural plate, which is the pnc domain (arrowhead). (H) A transverse
section of an embryo labeled as in panel F. tfap2c (blue) is expressed at high level in the ppr and nne, lateral to foxd3 expression (red) in pnc. (I–L) Dorsal and lateral
views of embryos at the indicated ages processed to reveal tfap2c. (I) In the head, and panel J, trunk at 24 hpf, expression of tfap2c is detected in surface ectoderm and
diencephalon (arrowhead). (K) At 36 hpf, tfap2c expression is reduced in surface ectoderm; (L) at 48 hpf, high level tfap2c expression is detected in the eye. Scale
bars: (A–G, I–L), 100 μm; (F′–H), 50 μm.
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tfap2c expression in neural crest has been down regulated below
detectable levels at this stage. At 24 hpf, tfap2c expression was
detected in a punctate pattern in the epidermis, but not in
migrating neural crest (Figs. 1I, J). At 36 hpf, tfap2c expression
is reduced or absent in surface ectoderm (Fig. 1K), and at
48 hpf, high level tfap2c expression is present in the eye (Fig.
1L). In summary, tfap2c is expressed in non-neural ectoderm at
gastrula stages through at least 24 hpf, and transiently in pre-
migratory neural crest.
Simultaneous reduction of Tfap2a and Tfap2c has non-additive
effects
To determine whether Tfap2c is required for early zebrafish
development, we injected embryos with an antisense morpho-
lino oligonucleotide (MO) targeting the tfap2c exon 3 splice
donor site (i.e., e3i3 MO) (Fig. 2A). RT-PCR and sequencing
of the major aberrant splice product revealed that e3i3 MO
causes a deletion of 38 nucleotides, resulting in a frame shift
and a severe truncation of the predicted protein, eliminating theDNA binding domain (Figs. 2A, B). However, wild-type
zebrafish embryos injected with this tfap2c MO developed
with normal morphology, pigmentation, and craniofacial
cartilage (Figs. 2E, 3C, G).
The similar expression patterns of tfap2a and tfap2c in early
embryos, and the similar binding specificity of Tfap2a and
Tfap2c in mammals (Bosher et al., 1996; McPherson and
Weigel, 1999) and amphibians (Zhang et al., 2006), suggested
that Tfap2a might compensate for lack of Tfap2c in embryos
injected with tfap2c MO. To test this model, we injected
embryos derived from tfap2a heterozygous mutant parents with
tfap2c e3i3 MO. One fourth of the embryos in this clutch
showed striking defects, detailed below, and a PCR-based
genotyping assay confirmed that the severely-affected embryos
were the tfap2a homozygous mutants (Genotyping data
presented in Supplementary Fig. S1) (100% of the tfap2a
mutants, n=7, and 0% of the wild-type and heterozygous
siblings, n=24, displayed the morphological phenotypes
described below). By contrast, tfap2a mutants injected with a
control MO were indistinguishable from uninjected tfap2a
mutants. To confirm that tfap2c e3i3 MO-induced phenotypes
342 W. Li, R.A. Cornell / Developmental Biology 304 (2007) 338–354resulted from effects on the tfap2c transcript, rather than on an
alternative transcript with fortuitous sequence similarity, we
designed an independent MO targeting the exon 4 splice
acceptor site of the tfap2c gene (i.e., i3e4 MO). We performed
RT-PCR and found that the i3e4 MO also disrupted tfap2csplicing (Fig. 2B). Injection of tfap2c i3e4 MO into wild-type
embryos had no effect on morphology, but in one fourth of
embryos derived from tfap2a heterozygous mutant parents, it
caused the array of phenotypes described below (7 of 30 i3e4
MO-injected embryos, not shown). 10 of 12 embryos co-
Fig. 3. tfap2a/c deficient embryos display non-additive defects in pigmentation and jaw morphology. (A–D) Dorsal views of live 72 hpf embryos. (A) Melanophores
are abundant on the dorsal aspect of the head in a control-MO injected wild-type embryo, slightly reduced in panel B, a control MO-injected tfap2amutant, normal in
panel C, a tfap2cMO-injected wild-type embryo, but absent from panel D, a tfap2a-/cMO embryo (6 of 6 tfap2a−/cMO embryos). (E–H) Ventral views of 4 dpf embryos
processed to reveal cartilage (alcian green), and bleached to remove pigment (except panel H). (E) Cartilages derived from mandibular (1st arch, m), hyoid (2nd arch,
h), and ceratobranchial (3rd–7th arches, cb) arches are seen in a control embryo. Pectoral fin (pf) is also visible. (F) A control MO-injected tfap2a homozygous mutant
embryo, with normal sized mandibular, but severely reduced hyoid and ceratobranchial cartilages, as previously reported (Schilling et al., 1996). (G) A tfap2c MO-
injected wild-type embryo, in which all craniofacial cartilages appear normal. (H) A tfap2a−/cMO embryo, in which ventral craniofacial cartilage elements and pectoral
fin are absent (10 of 10 tfap2a−/cMO embryos). (I) Ventral view of dissected neurocranium from a control embryo. (J) Ventral view of a tfap2a−/cMO embryo, shown at
higher magnification, only the mesoderm-derived posterior neurocranium is visible (10 of 10 tfap2a−/cMO embryos). e, ethmoid plate; pch, parachordal; t, trabeculae
cranii (Schilling et al., 1996). Scale bars: 100 μm.
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morphological features (Supplementary Fig. S1). These find-
ings suggest Tfap2a and Tfap2c have partially redundant
function in zebrafish embryogenesis.
We observed a range of morphological defects in live tfap2a
homozygous mutant embryos injected with tfap2c e3i3 MO
(hereafter, tfap2a−/cMO embryos). tfap2a−/cMO embryos could
be readily distinguished from siblings by 20 hpf based on a lack
of the yolk extension (not shown). In tfap2a−/cMO embryos at
28 hpf the yolk extension and tail were foreshortened, and anFig. 2. tfap2amutant embryos injected with tfap2cmorpholino (MO) display abnorma
showing the position of MOs used in this study; middle, effects of the tfap2c e3i3 M
exons, numbers refer to amino acids. TA, transactivation domain. DBD, DNA binding
exon 4 splicing acceptor site are shown in red. P1 and P2 are the primers used for the
which leads to a frame shift and introduces a stop codon at the end of exon 3. (B) tfap2c
with the primers P1 and P2 shown in panel A yielded a single band of the expected si
embryos (e3i3MO) yielded a smaller band of 519 bp. Amplification of cDNA from tfa
ladder. (C–F) Lateral views of live embryos at 28 hpf. In panel C, a wild-type emb
morphology and pigmentation. In panel D, a control MO-injected tfap2a homozy
melanophores. In panel E, a wild-type embryo injected with tfap2c e3i3 MO with n
injected with tfap2c e3i3MO (hereafter, tfap2a−/cMO embryo), with no visible pigmen
the hindbrain (asterisk). (G–L) Lateral views of the embryos shown in panels C and
(arrowhead in panel I) are visible in the control embryo but not in the tfap2a−/cMO em
panel K, the control embryo, contains two otoliths (arrowhead). While in panel L, the t
An enlarged view of the edema ventral to the hindbrain is also seen (asterisk). (M, N)
folds, as outlined in panel M, the control embryo, are virtually absent in panel N, the tfa
to indirect effects, because tfap2a and tfap2c expression are not detected in these tissedema was present ventral to the pharyngeal arches (Figs. 2F,
L). Lens and olfactory placodes were either not detectable or
highly reduced in size, and the retinas exhibited abnormal
morphology (Figs. 2H, J); these structures appeared normal in
control MO-injected wild-type or tfap2a mutant embryos (Figs.
2G, I, and not shown). Otic vesicles in tfap2a−/cMO embryos
were highly reduced in size, but always discernible, and usually
contained a single otolith (Fig. 2L). Otic vesicles in control
embryos and tfap2a mutants virtually always contain two
otoliths at this stage (Fig. 2K and not shown) (Solomon andl development in ectoderm-derived tissues. (A) Top, schematic of the tfap2c gene
O on the tfap2c transcript; bottom, the Tfap2c protein. Roman numerals refer to
domain. e3i3MO targeting the exon 3 splice donor site and i3e4MO targeting the
RT-PCR shown in panel B. tfap2c e3i3MO causes a deletion of 38 nucleotides,
RT-PCR results. Amplification of cDNA from uninjected wild-type embryos (wt)
ze of 557 bp, while amplification of 24 hpf cDNA from tfap2c e3i3MO injected
p2c i3e4MO injected embryos (i3e4MO) also yielded a smaller band. M, 100 bp
ryo injected with standard control MO (hereafter, control embryo) with normal
gous mutant embryo displaying normal morphology but reduced number of
ormal morphology and pigmentation. (F) A tfap2a homozygous mutant embryo
tation, an absence of yolk extension, a poorly extended tail, and edema ventral to
F at higher magnification. Olfactory placode (arrowhead in panel G) and lens
bryo (H, J) which also displays malformation of the ventral retina. Otic vesicle in
fap2a−/cMO embryo, it is reduced in size and contains a single otolith (arrowhead).
Lateral views of the same embryos shown in panels C and F at 72 hpf. Medial fin
p2a−/cMO embryo. Notochord and somites also appear abnormal, presumably due
ues. Scale bars: 100 μm.
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and contain mesenchymal cells of neural crest origin (Smith et
al., 1994), were normal in control MO-injected wild-type (Fig.
2M) and tfap2a mutant embryos (not shown), but were severely
shrunken in tfap2a−/cMO embryos (Fig. 2N). Pectoral fins,
which also appeared normal in tfap2a mutants (Fig. 3F), were
reduced or absent in tfap2a−/cMO embryos (Fig. 3H). In control
MO-injected tfap2a mutants, melanophores and iridophores
were moderately reduced in number, and xanthophores wereFig. 4. Neural crest and placode derivatives are absent or reduced in tfap2a/c defici
(Zn12 antibody) immunoreactivity (IR), revealing the presence of cranial ganglia ne
panel B, a tfap2a−/cMO embryo (9 of 10 tfap2a−/cMO embryos). (C–F) Lateral and (
control embryos anti-Hu IR reveals panel C, cranial ganglia surrounding the otic ves
vagal level, and (I), proximal enteric neurons, adjacent to gut (g), also at vagal le
embryo (8 of 8 tfap2a−/cMO embryos). (K, L) Dorsal and (M, N) lateral views of 28 h
(arrowheads) and (M) Schwann cells associated with lateral line processes (arrowhea
tfap2a−/cMO embryos). (O, P) Lateral views of 28 hpf embryos processed to reveal eya
panel O, a control embryo, but absent in panel P, a tfap2a−/cMO embryo (11 of 11 tf
(pfm) remains normal in the tfap2a−/cMO MO embryo (11 of 11 tfap2a−/cMO MO emb
is taken up by hair cells. In panel Q, a control embryo, DASPEI-positive hair cells in
tfap2a−/cMO embryo, DASPEI positive cells are not seen. (S, T) Dorsal anterior vie
olfactory placode is apparent in panel S, a control embryo. In panel R, a tfap2a−/cMO
11 tfap2a−/cMO embryos). gV, trigeminal ganglion; allg, anterior lateral line ganglio
lateral line ganglion; gAV, anteroventral lateral line ganglion; gVII, facial sensory g
vesicle. Scale bars: (A–R), 100 μm; (S, T), 50 μm.present (Fig. 3B and not shown) (Knight et al., 2004); by
contrast, tfap2a−/cMO embryos lacked pigment cells of all types
(Fig. 3D, and not shown). In tfap2a mutant embryos, cartilages
derived from the hyoid arch (arch 2) and the ceratobranchial
arches (arches 3–7) were reduced to various extents, whereas
cartilage elements derived from the first arch (Meckel's and
palatoquadrate) were relatively unaffected (Barrallo-Gimeno
et al., 2004; Knight et al., 2003) (Fig. 3F). By contrast, in
tfap2a−/cMO embryos cartilage from all arches was absent,ent embryos. (A, B) Lateral views of 28 hpf embryos processed for anti-HNK1
urons in panel A, a control MO-injected wild-type embryo, and their absence in
G–J) ventral views of 72 hpf embryos processed for anti-Hu IR. (C, E, G, I) In
icle (ot), (E), dorsal root ganglia (drg) in the trunk, (G), sympathetic neurons at
vel. (D, F, H, J) All of these neurons appear to be absent from a tfap2a−/cMO
pf embryos processed to reveal foxd3 expression, which labels (K) satellite cells
ds) in a control embryo, but not in panels L, N, a tfap2a−/cMO embryo (12 of 12
1 expression, which is detected in the lateral line migrating primordium (llmp) in
ap2a−/cMO MO embryos). eya1 expression in presumed pectoral fin mesoderm
ryos). (Q, R) Lateral head views of 4 dpf embryos incubated in DASPEI, which
the inner ear (arrowhead) and the neuromasts (arrows) are visible. In panel R, a
ws of 28 hpf embryos processed to reveal eya1 expression. eya1 expression in
embryo, a small cluster of eya1-expressing cells is present in this position (11 of
n; ac, acoustic ganglion; pllg, posterior lateral line ganglion; gAD, anterodorsal
anglion; gIX, glossopharyngeal ganglion; gX, vagus ganglion; e, eye; ot, otic
Fig. 5. Gene expression characteristic of neural crest is absent, but of the neural
plate border and pre-placodal region is present in tfap2a/c deficient embryos. (A,
B) Lateral views of 22 hpf embryos processed to reveal sox10 expression, which
is present in migratory neural crest streams (arrowheads) and the otic vesicle (ot)
in panel A, a control embryo; in panel B, a tfap2a−/cMO embryo, it is only present
in the ot (11 of 11 tfap2a−/cMO embryos). (C, D) Dorsal views of 24 hpf embryos
processed to reveal dlx2 expression, which is present in cranial migratory neural
crest streams (arrowheads) and brain in panel C, a control embryo, but only in the
latter in panel D, a tfap2a/c deficient embryo (10 of 10 tfap2a−/cMO embryos).
(E–N) Dorsal views of flat-mounted, 11 hpf embryos processed to reveal the
indicated markers. foxd3 and snai1b expression that are characteristic of
premigratory neural crest (pnc) cells are absent in embryos injected with tfap2a
e2i2MO and tfap2c e3i3MO (hereafter, tfap2aMO/cMO embryo) (foxd3, 27 of 27
tfap2aMO/c MO embryos; snai1b, 29 of 29 tfap2aMO/cMO embryos. Also not
shown, at the same stage, sox10, 29 of 29 tfap2aMO/cMO embryos). Expression of
pax3, msxb and dlx3b expression appear normal in tfap2aMO/cMO embryos
(100%, n is greater or equal to 30 tfap2aMO/cMO embryos for each gene, also not
shown, zic2b). Scale bars: 100 μm.
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remained (Figs. 3H, J). In summary, wild-type embryos injected
with tfap2c MO developed normally until at least 4 dpf, while
tfap2a−/cMO embryos displayed defects far exceeding those
detected in tfap2a mutants.
Neural crest derivatives are absent, and placode derivatives
reduced in tfap2a/c-deficient embryos
We assessed the presence of other neural crest and placode
derivatives by virtue of characteristic gene expression.
Neurons of cranial ganglia are derived from both of these
precursor populations (D'Amico-Martel and Noden, 1983). In
tfap2a mutants, there is severe reduction or loss of neurons in
epibranchial, distal enteric, and anterior lateral line ganglia, a
more modest reduction of neurons in trigeminal and dorsal
root ganglia, and apparently normal numbers of neurons in
posterior lateral-line, vagal, and sympathetic ganglia (Barrallo-
Gimeno et al., 2004; Holzschuh et al., 2003). In tfap2a−/cMO
embryos, there was a more extreme loss of neurons in
peripheral ganglia, such that trigeminal, vagal, sympathetic,
proximal enteric, and dorsal root ganglia were all highly
reduced in size or absent (Figs. 4B, D, F, H, J). Neural crest-
derived glial cells – including satellite cells in cranial ganglia
and Schwann cells associated with lateral line processes, both
of which are characterized by foxd3 expression (Kelsh et al.,
2000) – were completely absent from tfap2a−/cMO embryos
(Figs. 4L, N). The migrating lateral line primordium, which is
placode derived, was absent from tfap2a−/cMO embryos at
28 hpf, as determined by eya1 expression (Kozlowski et al.,
2005) (Fig. 4P). Neuromasts, which derive from the lateral-
line primordium and can be detected by DASPEI labeling of
hair cells, were absent in tfap2a−/cMO embryos at 3 dpf (Fig.
4R) (Harris et al., 2003). Finally, consistent with abnormal
olfactory placode morphology (Fig. 2H), eya1 expression in
olfactory placode was highly reduced in tfap2a−/cMO embryos
at 28 hpf (Fig. 4T). In summary, neural crest derivatives were
absent in tfap2a−/cMO embryos, and placode derivatives were
absent or severely reduced in size.
Simultaneous reduction of Tfap2a and Tfap2c eliminates the
neural crest but not the pre-placodal domain
We speculated that redundant activity of Tfap2a and
Tfap2c (hereafter referred to as Tfap2a/c activity) is required
for induction or maintenance of neural crest. In tfap2a
mutants, expression of dlx2 in migratory neural crest is highly
reduced in all but the first pharyngeal arch; however, early
expression of most neural crest markers appears to be normal,
except crestin expression is absent everywhere and foxd3
expression is reduced specifically in hindbrain neural crest
(Knight et al., 2003). In tfap2a−/cMO embryos, we found
expression of dlx2 and sox10 in migratory neural crest was
absent in the trunk and in all pharyngeal arches (Figs. 5B, D).
In addition, foxd3 expression at 11 hpf in premigratory neural
crest was absent from about one fourth of a clutch of embryos
derived from tfap2a heterozygous mutant parents and injectedwith tfap2c e3i3 MO (7 of 26 embryos, not shown). To
facilitate further evaluation of tfap2a/c-deficient embryos at
early stages, we employed a morpholino targeting the exon 2
donor site of tfap2a (i.e., tfap2a e2i2 MO). We have
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resemble tfap2a homozygous mutant embryos (O'Brien et al.,
2004). We found that embryos injected with both tfap2a e2i2
MO and tfap2c e3i3 MO (hereafter, tfap2aMO/cMO embryos)
recapitulate all of the morphological features of tfap2a−/cMO
embryos (95%, n=100 embryos, not shown). Expression of
foxd3, sox9b, sox10, and snai1b in pre-migratory neural crest
was eliminated in tfap2aMO/cMO embryos (Fig. 5, Supple-
mentary Fig. S2, and not shown). By contrast, expression of
the neural plate border markers pax3, msxb, and zic2b was
normal in tfap2aMO/cMO embryos (Fig. 5 and not shown), and
in all embryos derived from tfap2a heterozygous mutant
parents and injected with tfap2c e3i3 MO (not shown, n=40 or
more embryos examined for each gene). These findings impli-
cate Tfap2a/c activity in neural crest induction, and place it in
parallel to or possibly downstream of Pax3, Zic2b, and Msxb,
and upstream of Foxd3, Sox9, Sox10, and Snai1b activities.
The defects in the sensory placodes of tfap2a−/cMO embryos
suggested a failure in specification of the pre-placodal domain.
However, expression of dlx3b and eya1 genes, which are both
markers of the pre-placodal domain in wild-type embryos
(Akimenko et al., 1994; Kozlowski et al., 2005), was normal in
tfap2aMO/cMO embryos (Fig. 5N and Supplementary Fig. S2)
and all tfap2c MO-injected embryos derived from tfap2a
heterozygous mutant parents (not shown, n=40 or more
embryos or each gene). These results suggest that Tfap2a/c
activity is required for a step, or steps, that occurs during the
development of placodal derivatives subsequent to the estab-
lishment of the pre-placodal domain.
Rohon–Beard sensory neurons are reduced but not absent in
tfap2a/c deficient embryos
Rohon–Beard sensory neurons (RBs) reside in the dorsal
spinal cord but derive from the same neural plate domain as
neural crest (Cornell and Eisen, 2000; see also Jacobson, 1991).
Mutants with defective Delta/Notch signaling have super-
numerary RBs but lack trunk neural crest, suggesting that RBs
derive from precursor cells that are also competent to become
trunk neural crest, i.e., RB/NC precursors (Cornell and Eisen,Fig. 6. Rohon–Beard sensory neurons (RBs) are reduced but not absent in tfap2a/c de
tlxA expression, anterior to the left. RBs are abundant in panel A, a wild-type or tfap
Note that RBs are abnormally distributed in the latter, suggestive of abnormal pattern
dorsal spinal cord at 20 hpf. Error bars indicate standard deviation. Left column, em
n=23 embryos. Middle column, tfap2amutants injected with 5 ng tfap2c e3i3MO, n
n=8 embryos. (D, E) Dorsal views of flat mounted 12 hpf embryos stained for anti-I
anterior to the left. Premigratory neural crest (pnc) cells expressing foxd3 and RBs ex
are intermingled, as seen at higher magnification in panel D′ (corresponds to box in p
while RBs are still present, as shown at higher magnification in panel E′ (11 of 40 inje
flat mounted 11 hpf embryos processed to reveal prdm1 expression, anterior to the le
region (ppr), in the neural plate boundary in the trunk (panel F′ corresponds to box in
is expressed in scattered cells at the neural plate border (arrowheads) (panel G′ cor
heterozygotes). (H–M) Dorsal trunk views of flat mounted 12.5 hpf embryos. isl1
tfap2a−/cMO embryos, isl1 expression is moderately reduced (16 of 56 injected embry
L, 12 of 58 injected embryos derived from tfap2alow heterozygotes). (J) In an embryo d
MO and ngn1 MO, isl1 expression in lateral neural plate, indicating RBs, is absent (
mutant injected with tfap2cMO and ngn1MO, foxd3 expression is absent (M, 16 of
12.5 hpf embryo processed to reveal anti-Islet IR (brown, nuclear) and tfap2amRNA
IR also express tfap2a (arrowheads). There are also RBs that are devoid of tfap2a ex2000, 2002). These data suggest the default fate for RB/NC
precursors is RB, but when exposed to the cell-surface ligand
Delta, which is expressed on nascent RBs, they adopt the
alternate fate of neural crest. Inhibition of ngn1 in Delta/Notch
pathway mutants will substitute for Delta signaling in RB/NC
precursors, thereby eliminating RBs and restoring trunk neural
crest in these mutants (Cornell and Eisen, 2002).
RBs were reported to be slightly reduced in tfap2a mu-
tants (Knight et al., 2004), and our expectation was that like
neural crest they would be absent from tfap2a/c deficient
embryos. RBs are characterized by expression of tlxA at 20 hpf
(Andermann and Weinberg, 2001). We injected control MO or
tfap2c MO into embryos derived from tfap2a heterozygotes,
fixed and processed embryos at 20 hpf, and counted tlxA-
positive cells. We found that tfap2a−/cMO embryos, which
could be recognized by their characteristic morphology,
contained about 60% of the average number of RBs in control
MO-injected embryos, i.e., both tfap2a mutants and their
siblings (tfap2amutants could not be un-ambiguously identified
based on their phenotype of reduced RBs) (Figs. 6A–C). To
confirm that reduction of Tfap2a/c activity has a more severe
impact on neural crest cells than RBs, we processed 12 hpf
embryos derived from tfap2a heterozygous mutant parents
injected with tfap2c MO to reveal foxd3 mRNA and anti-Islet
IR (a marker of RBs) simultaneously. One fourth of these,
presumed to be tfap2a−/cMO embryos, were completely
devoid of foxd3 expression (Fig. 6E), yet had residual RBs
(Figs. 6E, E′). The transcription factor Prdm1/Blimp1 is
implicated in the early development of neural crest and RBs
(Artinger et al., 1999; Hernandez-Lagunas et al., 2005; Roy
and Ng, 2004). In contrast to neural crest marker expression,
which was absent, and neural plate border expression, which
was normal, prdm1 expression was highly reduced but not
completely absent in tfap2aMO/cMO embryos (not shown) and
in about one fourth of embryos derived from tfap2a hetero-
zygous mutant parents injected with tfap2c MO (Figs. 6G, G′).
These findings are consistent with prdm1 being expressed in
Tfap2a/c-dependent RB/NC precursors, and in a previously
unknown cell type, Tfap2a/c-independent RB precursor cells
(Fig. 10, see Discussion).ficient embryos. (A, B) Dorsal trunk views of 20 hpf embryos processed to reveal
2a mutant embryo, but moderately reduced in panel B, a tfap2a−/cMO embryo.
ing in the dorsal neural tube. (C) The average number of tlxA-positive cells in the
bryos derived from tfap2a heterozygous mutants and injected with control MO,
=5 embryos. Right column, tfap2amutants injected with 10 ng tfap2c e3i3MO,
slet immunoreactivity (brown, nuclear) and foxd3 mRNA (purple, cytoplasmic),
pressing anti-Islet IR are present in panel D, a control embryo. RBs and pnc cells
anel D). In panel E, a presumed tfap2a−/cMO embryo, foxd3 expression is absent
cted embryos derived from tfap2a heterozygous mutants). (F, G) Dorsal views of
ft. In panel F, a control embryo, prdm1 expression is detected in the pre-placodal
panel F), and in adaxial cells (A). (G) In a presumed tfap2a−/cMO embryo, prdm1
responds to box in panel G) (7 of 29 injected embryos derived from tfap2alow
(H) and foxd3 (K) expression shown in control embryos. (I) In the presumed
os derived from tfap2alow heterozygotes), while foxd3 expression is absent (panel
erived from tfap2a heterozygous mutant parents and co-injected with tfap2c e3i3
48 of 51 tfap2cMO and ngn1 MO injected embryos). (M) In a presumed tfap2a
53 injected embryos derived from tfap2alow heterozygotes). (N) Dorsal view of a
(purple, cytoplasmic), anterior to the left. Some RBs that are positive for anti-Islet
pression in the cytoplasm (arrows). Scale bars: (A–M), 100 μm; (N), 50 μm.
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expression in tfap2a/c-deficient embryos might merely reflect
incomplete suppression of Tfap2a/c activity. Residual Tfap2a/c
activity might suffice to promote induction of a few RB/NC
precursors. If these were sparsely distributed they might not
receive a Delta signal and therefore would be expected to adopt
the RB fate. A prediction of this model is that the number of
RBs present should be highly dependent on the thoroughness of
the knock-down of tfap2a and tfap2c. To test this prediction,
we used tfap2a mutants and injected either twice (5 ng) or 4
times (10 ng) the amount of tfap2c e3i3 MO necessary to
eliminate foxd3 expression (2.5 ng), and counted RBs at 20 hpf.
The number of RBs in tfap2a mutants injected with either doseof tfap2c MO was the same (Fig. 6C), i.e., about 60% of the
number present in control embryos, arguing against the
possibility that poor distribution of tfap2c MO explains the
presence of residual RBs in tfap2a−/cMO embryos. A second
prediction of the model that RBs in tfap2a/c deficient embryos
derive from RB/NC precursors that fail to receive a Delta signal
is that inhibition of ngn1 should convert these residual RBs to
neural crest. We injected ngn1 MO and tfap2c MO into
embryos derived from tfap2a mutant parents. At 12 hpf, as
expected, all such embryos lacked isl1 expression in lateral
neural plate, reflecting the requirement for Ngn1 in RB
development (Fig. 6J) (Andermann et al., 2002; Cornell and
Eisen, 2002). Significantly, one fourth of similarly treated
348 W. Li, R.A. Cornell / Developmental Biology 304 (2007) 338–354embryos utterly lacked foxd3 expression, that is, we did not
observe expression of foxd3 in place of RBs as predicted by this
model (Fig. 6M). Together these results argue against the
possibility that residual RBs in tfap2a/c deficient embryos are
derived from RB/NC precursors.
An alternative model is that there are distinct subsets of
RBs, i.e., Tfap2a/c-dependent and -independent subsets.
Genetically distinct subsets of RBs might be expected to
have distinct expression profiles; specifically, the Tfap2a/c-
independent subset might never express tfap2a. Consistent
with this possibility, in 12.5 hpf embryos processed to reveal
anti-Islet IR and tfap2a mRNA we detected unambiguous
examples of Islet-IR-positive RBs that expressed tfap2a and
those that did not (Fig. 6N). This result supports the
existence of a Tfap2a/c-independent class of RBs (see
Discussion).
Requirement for Tfap2a/c activity in neural crest induction is
cell autonomous
To determine whether the requirement for Tfap2a/c in neural
crest induction is cell-autonomous, we created genetic chimerasFig. 7. Chimera experiments suggest requirement for Tfap2a/c activity in neural cr
embryos. (A) A chimera derived from a wild-type host and a wild-type donor. Biotin-
total of 40 biotin-labeled foxd3-expressing cells were found, 3 embryos scored). (B) A
donor derived cells expressing foxd3 are visible (arrowhead in panel B′) (150 of 15
derived from a wild-type host and a tfap2a−/cMO donor embryo. A biotin-labeled, fo
higher magnification in panel C′, arrowhead) (of 95 biotin-labeled cells within the ho
48 hpf a chimera derived from a tfap2aMO/cMO host and a wild-type donor. Melan
melanophores are labeled with biotin, indicating that they are donor-derived (out of 3
melanophores and lacked melanophores without biotin). Scale bars: (A–D), 100 μmwith blastula transplants. First, we transplanted cells from 4 hpf
wild-type donors injected with a lineage tracer into wild-type
host embryos. At 12 hpf, we processed embryos to reveal the
lineage tracer in brown and foxd3 expression in blue. Double-
labeled donor-derived cells were readily distinguished from
host-derived cells expressing foxd3 singly (Figs. 7A, A′). Next,
we repeated this experiment but used host embryos from tfap2a
heterozygous mutant parents and injected with tfap2c MO. In
tfap2a−/cMO hosts at 12 hpf, which were identified by a severe
reduction of foxd3 expression, all cells expressing foxd3 were
donor-derived (with one exception out of the 151 foxd3-
expressing cells scored) (Figs. 7B, B′). In similar chimeras
grown to 48 hpf, made with wild-type donors and tfap2aMO/
cMO hosts, virtually all melanophores were found to contain
lineage tracer (Figs. 7D, D′). These findings indicate that bona
fide neural crest can develop from wild-type cells that are
flanked by tfap2a/c-deficient non-neural ectoderm. We con-
ducted the same experiment in reverse, using tfap2a−/cMO
donors (determined by raising donors to 28 hpf after the
transplant procedure) and wild-type hosts. In such chimeras,
donor-derived cells were never found to express foxd3 (Figs.
7C, C′), and in similar experiments, using a host strain that lacksest induction is cell autonomous. (A–C) Dorsal views of flat mounted 12 hpf
labeled, donor derived cells are seen to express foxd3 (arrowhead in panel A′) (a
chimera derived from a tfap2a−/cMO host and a wild-type donor. Biotin-labeled,
1 foxd3-expressing cells were biotin-labeled, 5 embryos scored). (C) A chimera
xd3 negative cell is seen interspersed with host cells expressing foxd3 (shown at
st foxd3 domain, none expressed foxd3, 6 embryos scored). (D) Lateral view of a
ophores are visible in the head. As seen at higher magnification in panel D′,
0 such chimeras that survived to 48 hpf, 11 had at least 5 or more biotin-positive
; (A′–D′), 50 μm.
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melanophores, tfap2a/c-deficient donor cells were never found
to become melanophores (Supplementary Fig. S3). These
results show that even when flanked by wild-type non-neural
ectoderm, Tfap2a/c deficient cells were not competent to
become neural crest. Together these transplant studies strongly
support a cell-autonomous requirement for Tfap2a/c activity in
neural crest induction.
Tfap2a/c activity is required for neural crest specification
An absence of neural crest in tfap2a/c-deficient embryos was
consistent with several possible roles for Tfap2a/c activity in
neural crest development, including promotion of neural crest
survival, proliferation, specification, or a combination of these.
To test for a role for Tfap2a/c activity in neural crest survival,
we fixed control and tfap2aMO/cMO embryos at 11 hpf and
processed them for TUNEL, a marker of apoptotic cell death.
We did not detect a gross increase in TUNEL-positive cells in
tfap2aMO/cMO embryos (Figs. 8A, B), although we recognized
that a small or highly localized increase in TUNEL-positive
cells might have been difficult to detect. Therefore, we
incubated control and tfap2aMO/cMO embryos in the pan-
caspase inhibitor, zVAD-fmk (Hsieh et al., 2003; Williams et al.,
2000). We found this treatment drastically reduced levels of cell
death in both populations, but it did not rescue foxd3 expression
in the latter (Figs. 8C–F). We conclude that excessive cell death
is unlikely to account for the absence of neural crest in tfap2a/c-
deficient embryos.
To test for a role for Tfap2a/c in promoting proliferation,
we used BrdU incorporation to label cells in S-phase in
tfap2aMO/cMO embryos. Because neural crest is not detectableFig. 8. Loss of neural crest in tfap2a/c deficient embryos is concomitant with an
expansion of neural plate. (A–D) Lateral views, dorsal to the right, of either
uninjected wild-type or tfap2aMO/cMO embryos fixed at 11 hpf and processed to
reveal dying cells with TUNEL. A wild-type embryo and a tfap2aMO/cMO
embryo have comparable numbers of TUNEL-positive cells [control embryos,
62±70 (average±standard deviation), n=13; tfap2aMO/cMO embryos, 42±38,
n=28; unpaired t test, p=0.23]. (C) A wild-type embryo, and (D) a tfap2aMO/
cMO embryo, after treatment with caspase inhibitor zVAD-fmk. Reduced levels
of cell death are seen in both of them (control embryos, 10±14, n=19, p<0.005
in comparison to untreated controls; tfap2aMO/cMO embryos, 17±13, n=18,
p<0.05, in comparison to untreated tfap2aMO/cMO embryos). Dorsal views,
anterior to the left, of panel E, a wild-type embryo, and panel F, a tfap2aMO/cMO
embryo treated with zVAD-fmk and processed to reveal foxd3 expression at
11 hpf. foxd3 expression is absent in the premigratory neural crest (pnc) domain
of the zVAD treated tfap2aMO/cMO embryo (30 of 30 zVAD treated tfap2aMO/
cMO embryos). (G, H) Ventral views, anterior to the left, of embryos incubated in
BrdU for 20 min at 10 hpf, fixed at 11 hpf, and stained for anti-BrdU IR. The
number of anti-BrdU IR positive cells within a 200×200 μm region of ventral
ectoderm (boxes in panels G and H) was comparable in both groups (control
embryos, 37±6 anti-BrdU IR positive cells, n=9 embryos; tfap2aMO/cMO
embryos, 35±7 anti-BrdU IR positive cells, n=9 embryos; unpaired t test,
p=0.48). (I, J) Dorsal views of 11 hpf embryos processed to reveal sox2
expression, labeling neural plate (np), and dlx3b expression, labeling the pre-
placodal region (ppr). (I′, J′) Close-up views of right side of embryos shown in
panels I and J, respectively. The space between these two expression domains,
normally occupied by premigratory neural crest (asterisk in panel I′), is absent in
the tfap2aMO/cMO embryo (J, 30 of 32 tfap2aMO/cMO embryos). Scale bars:
(A–J), 100 μm; (I′, J′), 50 μm.in these embryos, we counted BrdU-positive cells in non-
neural ectoderm, which expresses tfap2a and tfap2c. We did
not detect a significant difference in the number of BrdU-
labeled cells between control and tfap2aMO/cMO embryos
(Figs. 8G, H). While it is possible that Tfap2a/c activity is
required for proliferation of neural crest, we note that if this
were its only function in neural crest, we would have
expected tfap2a/c deficient cells to express foxd3 when
transplanted into the neural crest domain of control embryos,
which was not observed (Figs. 7C, C′).
We reasoned that if Tfap2a/c activity was required for neural
crest specification, prospective neural crest cells would adopt an
alternative fate in tfap2a/c-deficient embryos. We found that
wild-type embryos fixed at 11 hpf and processed to reveal sox2,
a marker of the neural plate (Okuda et al., 2006), and dlx3b, a
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exhibit a patch of unlabeled cells between these two expression
domains which we presume to be neural crest (Figs. 8I, I′).
However, in tfap2aMO/cMO embryos, this space is absent (Figs.
8J, J′). Because dlx3b expression is unchanged in tfap2aMO/
cMO embryos (Fig. 5N), this finding suggests that presumptiveFig. 9. Misexpression of Xenopus TFAP2A expands neural crest into the neural
plates. (A, C, E, G, I) Uninjected control embryos or (B, D, F, H, J) embryos co-
injected with RNA encoding β-galactosidase and GRXAP2, treated with
dexamethasone at 8 hpf. (A–H) Embryos fixed at 11 hpf, and processed to reveal
β-galactosidase activity (turquoise) (B, D, F, H) and expression of the indicated
gene (dark blue). Expression of neural crest markers is seen to be expanded into
the rostral domain of the neural plate on the injected side of the embryo (asterisk)
(foxd3, 29 of 37 embryos; snai1b, 31 of 40 embryos; sox9b, 34 of 45 embryos)
while expression of neural plate marker sox2 is decreased on the injected side
(37 of 50 embryos). (I, J) Lateral views of live embryos at 36 hpf, showing a
massive expansion of melanophores in the GRXAP2-injected embryo (27 of 34
RNA-injected embryos). Scale bars: 100 μm.neural crest converts to neural plate in tfap2a/c-deficient
embryos, and thus that Tfap2a/c activity is necessary to assign
ectoderm cells to the neural crest lineage.
Overexpression of tfap2a induces ectopic neural crest
As a positive test of the ability of Tfap2-type activity to
induce neural crest we conducted a misexpression experiment.
We found that injection of RNA encoding full-length Tfap2a
into tfap2aMO/cMO embryos efficiently rescued foxd3 expres-
sion at 11 hpf (Supplementary Fig. S4). Injection of tfap2a
mRNA into wild-type embryos expanded neural crest expres-
sion of foxd3 (not shown), although abnormal gastrulation in
these embryos complicated interpretation of this finding. To
circumvent the effect of ectopic Tfap2a on gastrulation, we
injected RNA encoding an dexamethasone-inducible form of X.
laevis Tfap2a, GRXAP2 (Luo et al., 2005), added dexametha-
sone at mid-gastrulation (6 hpf), fixed embryos at 11 hpf, and
processed them to reveal expression of foxd3 or other early
markers of premigratory neural crest. In such embryos, which
appeared to undergo gastrulation normally, we detected ectopic
expression of foxd3, snai1b, sox9b, and sox10 in the neural
plate (Figs. 9B, D, F, and not shown), and reduced expression of
neural plate marker sox2 (Fig. 9H). Moreover, when such
embryos were allowed to develop to 36 hpf, they often
displayed patches of supernumerary melanophores (Fig. 9J),
possibly resulting from a conversion of neural plate to neural
crest, although abnormal growth within the melanophore
lineage would also explain this finding. The results of these
gain-of-function experiments are consistent with a requirement
for Tfap2a/c-activity in neural crest induction.
Discussion
Requirement for Tfap2-type activity in neural crest induction is
conserved
Our data reveal that in zebrafish Tfap2a and Tfap2c
function redundantly in neural crest induction and in
development of other non-neural ectoderm derivatives. While
neural crest induction occurs normally in embryos deficient in
tfap2c (present study), and largely normally in embryos
deficient in tfap2a (Knight et al., 2003; O'Brien et al., 2004),
it appears to fail altogether in embryos deficient in both tfap2a
and tfap2c. Additional phenotypes observed in tfap2a/c-
doubly deficient embryos, but not in embryos singly deficient
in either gene, include a failure of lens, ear, and olfactory
placode to develop normally, and abnormal epidermal
development, as revealed by shrunken medial fin folds.
These phenotypes reveal that Tfap2a and Tfap2c can
compensate for each other's absence in many contexts during
zebrafish development. These proteins also appear to coop-
erate in mouse extra-embryonic tissue (Winger et al., 2006).
We predict that compensatory activity of Tfap2c explains why
neural crest induction occurs normally in mouse Tcfap2a
homozygous mutants. Importantly, our results suggest that a
role for Tfap2-type activity in neural crest induction is a
Fig. 10. Model for the role of Tfap2a/c activity in specification of trunk neural
crest and RBs. At cranial levels, Tfap2a and Tfap2c, acting redundantly in neural
plate border precursor (NPB) cells and in concert with other transcription factors
expressed in these cells (Msx, Pax, and Zic family members), specify neural
crest. At trunk levels, Tfap2a/c activity specifies RB/neural crest (NC) precursor
cells, which may be identified by expression of prdm1. In tfap2a/c deficient
embryos, RB/NC precursors are lost, resulting in the loss of NC, which is
characterized by expression of foxd3, snai1b, sox10, and other genes, and a
subset of RBs. The RBs that remain in tfap2a/c deficient embryos derive from a
hypothetical precursor cell with potential to become RB and other unidentified
neural plate (NP) cells (i.e., the RB/NP precursor). The RB/NP precursor cell
may also be characterized by prdm1 expression. Alternatively in the trunk,
Tfap2a/c activity governs specification of NC from RB/NC precursors, in which
case all RBs may derive from RB/NC precursors.
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possibly in mice, this role is shared between two closely related
Tfap2 family members, Tfap2a and Tfap2c. In frog embryos
this role is largely carried out by Tfap2a, but also possibly in
part by Tfap2c because inhibition of TFAP2A reduces, but does
not completely eliminate, neural crest (Luo et al., 2003).
Cell-autonomous Tfap2-type activity is required for neural
crest induction
Many previous studies have shown that Tfap2-type activity
can regulate the balance between cell proliferation and
differentiation or death (reviewed in Eckert et al., 2005).
The present findings, together with earlier work in frog (Luo
et al., 2003), suggest that Tfap2-type activity can also govern
cell fate specification, in this case, the choice of an
ectodermal cell to become neural crest. Several alternative
explanations for the loss of neural crest in tfap2a/c deficient
embryos were ruled out. For instance, this loss might have
resulted from conversion of posterior neural tissue to anterior,
from which neural crest does not arise. Indeed, tfap2a/c
deficient embryos display reduced extension of the tail,
consistent with anteriorization of the embryo, perhaps
reflecting regulation of tfap2a and tfap2c by the well-
known posteriorizing factor retinoic acid (Oulad-Abdelghani
et al., 1996; Wanner et al., 1996). However, arguing against a
wholesale conversion of neural tissue to a rostral identity,
multiple derivatives of the spinal cord are present in tfap2a/c
deficient embryos, including primary motoneurons, a subset
of RBs, and spt-expressing interneurons (WL and RAC,
unpublished observations). In addition, changes in prolifera-
tion or cell death did not appear to be sufficient to account for
the absence of neural crest in tfap2a/c-deficient embryos; we
note that if either of these were the explanation, a change
would have been expected in msxb expression, whose domain
overlaps the neural crest (Phillips et al., 2006; RAC,
unpublished observations). Rather, our observation that sox2
is expanded in tfap2a/c deficient embryos suggests neural
crest is converted to neural plate in such embryos. We predict
that a dorsal or intermediate spinal cord fate is expanded in
tfap2a/c deficient embryos. Although we have not yet
identified such a fate, we note that in such embryos, RBs
are unusually widely distributed in the medio-lateral dimen-
sion, consistent with abnormal dorso-ventral patterning of the
spinal cord. It is noteworthy that Tfap2-type activity is also
required for epidermis-specific gene expression (Luo et al.,
2002). Whether Tfap2-type activity induces neural crest
versus epidermis may depend on the presence of specific
cofactors, or the absence of specific repressors. Msx, Pax, and
Zic family members are candidates for Tfap2 co-factors
during induction of neural crest specific genes (Monsoro-Burq
et al., 2005).
The absence of neural crest in tfap2a/c-deficient embryos did
not immediately reveal which tissues require Tfap2a/c expres-
sion for neural crest induction. There is strong evidence that
neural crest patterning depends on Tfap2-type activity in
surrounding tissues (Brewer et al., 2004; Knight et al., 2005).However, our transplant studies support a cell-autonomous
requirement for Tfap2a/c-activity during neural crest induc-
tion. Because tfap2c expression is rapidly down regulated in
neural crest, Tfap2a/c function in neural crest induction must
occur during gastrula stage. At later stages, expression of
tfap2a members persists in migratory neural crest and many
of its derivatives. The cell autonomous function of Tfap2-type
activity within neural crest (i.e., subsequent to its induction) is
unknown, but conceivably includes control of survival,
proliferation, or patterning. Within neural crest derivatives,
Tfap2-type activity promotes Kit expression in melanocytes
(Brewer et al., 2004), tyrosine hydroxylase expression in
sympathetic neurons (Holzschuh et al., 2003; Kim et al.,
2001), and hoxa2 expression in cranial neural crest streams
(Maconochie et al., 1999). Identification of all functions
mediated by Tfap2-type activity in neural crest will require
simultaneous, tissue-specific knockdown of each tfap2 family
members expressed in neural crest.
A subset of RBs may be independent of Tfap2-type activity
The persistence of RBs in tfap2a/c-deficient embryos is
consistent with several models (Fig. 10). In one, Tfap2a/c
activity is required for specification of RB/NC precursors, but
tfap2a−/cMO embryos have sufficient residual Tfap2a/c activity
to allow induction of a few such precursors. These all adopt the
RB fate because they are sparsely distributed and do not receive
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crest. While we did not find the number of RBs to be highly
dependent on the dose of injected tfap2c MO, maternally
encoded Tfap2c may persist in tfap2a−/cMO embryos at
sufficient levels to permit induction of some RB/NC precursors.
If this were the case, however, we would have expected
injection of ngn1 MO into tfap2a−/cMO embryos to convert
residual RBs to foxd3-positive neural crest cells, which it did
not. An alternative model is that Tfap2a/c activity is not
required for specification of RB/NC precursors, but rather for
the subsequent specification of neural crest from these
precursors (Fig. 10). Our data are consistent with this model,
but we do not favor it because it does not explain the reduction
of RBs in tfap2a/c-deficient embryos at neural plate stages.
Finally, in our preferred model, a subset of RBs is derived from
Tfap2a/c-dependent RB/NC precursors, and another subset is
derived from Tfap2a/c-independent precursor cells, presumably
present in the neural plate (NP) (i.e., an RB/NP precursor) (Fig.
10). In frog embryos a lineage study revealed that at least some
RBs derive from a progenitor cell at the 512-cell stage that does
not give rise to neural crest (referenced in Jacobson, 1991).
Different subsets of RBs might be expected to have distinct
expression profiles, and we found that at the 6-somite stage not
all RBs expressed tfap2a. We cannot rule out the possibility that
all RBs initially express tfap2a but a subset of them by 6-somite
stage no longer does so. Nonetheless, it is an intriguing
hypothesis that the RBs that express tfap2a represent the subset
of RBs that derive from RB/NC precursor cells. Lineage studies
correlated with gene expression analyses will be required to test
this possibility.
Finally, we note that the possibility that a subset of RBs is
independent of Tfap2a/c activity is consistent with an earlier
proposal that RBs predate the neural crest in evolutionary terms
(Fritzsch and Northcutt, 1993). This hypothesis was partially
based on the presence of sensory neurons in the dorsal central
nervous system of Amphioxus, a modern cephalochordate
believed to share features with the hypothesized vertebrate
precursor (Bone, 1960). Whatever the relationship between RBs
and neural crest, evidence that Tfap2-type activity is a conserved
requirement for neural crest induction supports the model that
the emergence of neural crest during evolution required
modification of the ancestral Tfap2 gene's regulatory domain
to expand Tfap2 expression from the presumptive epidermis into
the lateral neural plate (Meulemans and Bronner-Fraser, 2005).
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